Cargando…
A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015
PURPOSES: We aimed to clarify the real-world status of breast cancer surgery and the cost in China. METHODS: This cross-sectional survey relied on data obtained from the hospitalization summary reports (HSRs) in 77 top-ranked (grade 3A) hospitals in China to analyze breast cancer patients who underw...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086896/ https://www.ncbi.nlm.nih.gov/pubmed/35558511 http://dx.doi.org/10.3389/fonc.2022.857359 |
_version_ | 1784704105729490944 |
---|---|
author | Zhao, Rong Jin, Meng Gao, Jinnan Zhang, Linhui Tao, Liyuan Bao, Xiaoyuan |
author_facet | Zhao, Rong Jin, Meng Gao, Jinnan Zhang, Linhui Tao, Liyuan Bao, Xiaoyuan |
author_sort | Zhao, Rong |
collection | PubMed |
description | PURPOSES: We aimed to clarify the real-world status of breast cancer surgery and the cost in China. METHODS: This cross-sectional survey relied on data obtained from the hospitalization summary reports (HSRs) in 77 top-ranked (grade 3A) hospitals in China to analyze breast cancer patients who underwent surgery between January 2015 and December 2015. The surgery and cost were mainly evaluated. RESULTS: Overall, 31,900 breast cancer patients underwent surgeries in 77 hospitals. The mean age in our study was 51.5 years (SD, 11.7 years). The primary types of surgical procedures were mastectomy (n = 24,629, 77.2%) and breast-conserving surgery (6,210, 19.5%). The rate of mastectomy was the highest at age band 50–65 years (n = 10,861, 82.1%) and in non-first-tier cities (n = 7,651, 88.4%) as well as in Northeast China (n = 3,107, 93.2%). The rate of breast-conserving surgery was less than 10% in non-first-tier cities (9.8%), Southwest China (6.1%), and Northeast China (5.8%). The median cost was $3,352.4 (interquartile range (IQR), $2,492.6–4,588.0). Mastectomy cost was significantly higher than breast-conserving surgery cost in both different city tiers and regional distribution except Northeast China (p < 0.001). CONCLUSIONS: This study demonstrated that the main breast cancer surgery in Chinese 3A hospitals was mastectomy and that the cost varied both across and within geographic regions and city tiers. This information helps describe the real-world status of breast surgery and the cost in China. |
format | Online Article Text |
id | pubmed-9086896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90868962022-05-11 A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 Zhao, Rong Jin, Meng Gao, Jinnan Zhang, Linhui Tao, Liyuan Bao, Xiaoyuan Front Oncol Oncology PURPOSES: We aimed to clarify the real-world status of breast cancer surgery and the cost in China. METHODS: This cross-sectional survey relied on data obtained from the hospitalization summary reports (HSRs) in 77 top-ranked (grade 3A) hospitals in China to analyze breast cancer patients who underwent surgery between January 2015 and December 2015. The surgery and cost were mainly evaluated. RESULTS: Overall, 31,900 breast cancer patients underwent surgeries in 77 hospitals. The mean age in our study was 51.5 years (SD, 11.7 years). The primary types of surgical procedures were mastectomy (n = 24,629, 77.2%) and breast-conserving surgery (6,210, 19.5%). The rate of mastectomy was the highest at age band 50–65 years (n = 10,861, 82.1%) and in non-first-tier cities (n = 7,651, 88.4%) as well as in Northeast China (n = 3,107, 93.2%). The rate of breast-conserving surgery was less than 10% in non-first-tier cities (9.8%), Southwest China (6.1%), and Northeast China (5.8%). The median cost was $3,352.4 (interquartile range (IQR), $2,492.6–4,588.0). Mastectomy cost was significantly higher than breast-conserving surgery cost in both different city tiers and regional distribution except Northeast China (p < 0.001). CONCLUSIONS: This study demonstrated that the main breast cancer surgery in Chinese 3A hospitals was mastectomy and that the cost varied both across and within geographic regions and city tiers. This information helps describe the real-world status of breast surgery and the cost in China. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086896/ /pubmed/35558511 http://dx.doi.org/10.3389/fonc.2022.857359 Text en Copyright © 2022 Zhao, Jin, Gao, Zhang, Tao and Bao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhao, Rong Jin, Meng Gao, Jinnan Zhang, Linhui Tao, Liyuan Bao, Xiaoyuan A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title | A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title_full | A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title_fullStr | A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title_full_unstemmed | A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title_short | A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015 |
title_sort | cross-sectional study of breast cancer surgery and the cost based on data from 77 chinese 3a hospitals in 2015 |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086896/ https://www.ncbi.nlm.nih.gov/pubmed/35558511 http://dx.doi.org/10.3389/fonc.2022.857359 |
work_keys_str_mv | AT zhaorong acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT jinmeng acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT gaojinnan acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT zhanglinhui acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT taoliyuan acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT baoxiaoyuan acrosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT zhaorong crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT jinmeng crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT gaojinnan crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT zhanglinhui crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT taoliyuan crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 AT baoxiaoyuan crosssectionalstudyofbreastcancersurgeryandthecostbasedondatafrom77chinese3ahospitalsin2015 |